References
- Wolf PA, Dawber TR, Thomas HEJ, et al. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology 1978;28:973-7
- Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. Arch Intern Med 1987;147:1561-4
- Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991;22:983-8
- Gutierrez C, Blanchard DG. Atrial fibrillation: diagnosis and treatment. American Academy of Famlily Physicians 2011;83:61-68
- January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary. J Am Coll Cardiol 2014;64:2246-80
- Pharmacy Quality Alliance (PQA). Technical Specifications for PQA Approved Measures. Springfield, VA: Pharmacy quality Alliance 2014
- Guérin A, Lin J, Jhaveri M, et al. Outcomes in atrial fibrillation patients on combined warfarin & antiarrhythmic therapy. Int J Cardiol 2013;167:564-9
- Chao T-F, Lin Y-J, Chang S-L, et al. Can oral anticoagulants be stopped safely after a successful atrial fibrillation ablation? J Thoracic Dis 2015;7:172-7
- Calkins H, Kuck KH, Cappato R, et al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. J Intervent Card Electrophysiol 2012;33:171-257
- Levitt HL, Toor SZ, Coplan NL. Is there a need to continue anticoagulation following “successful” atrial fibrillation ablation? Prev Cardiol 2009;12:39-42
- Winkle RA, Mead RH, Engel G, et al. Discontinuing anticoagulation following successful atrial fibrillation ablation in patients with prior strokes. J Intervent Card Electrophysiol 2013;38:147-53
- Nau DP. Proportion of Days Covered (PDC) as a Preferred Method of Measuring Medication Adherence. http://ep.yimg.com/ty/cdn/epill/pdcmpr.pdf. Accessed December 05, 2016.
- Yao X, Abraham NS, Alexander GC, et al. Effect of adherence to oral anticoagulants on risk of stroke and major bleeding among patients with atrial fibrillation. J Am Heart Assoc 2016;5:e003074
- McHorney CA, Crivera C, Laliberté F, et al. Adherence to non-vitamin-K-antagonist oral anticoagulant medications based on the Pharmacy Quality Alliance measure. Curr Med Res Opin 2015;31:2167-73
- Crivera C, Nelson WW, Bookhart B, et al. Pharmacy quality alliance measure: adherence to non-warfarin oral anticoagulant medications. Curr Med Res Opin 2015;31:1889-95
- Magee LA, von Dadelszen P, Rey E, et al. Less-tight versus tight control of hypertension in pregnancy. N Engl J Med 2015;372:407-17
- Al-Khalili F, Lindström C, Benson L. Adherence to anticoagulant treatment with apixaban and rivaroxaban in a real-world setting. Clin Trials Regulatory Sci Cardiol 2016;18:1-4
- Alberts MJ, Peacock WF, Fields LE, et al. Association between once- and twice-daily direct oral anticoagulant adherence in nonvalvular atrial fibrillation patients and rates of ischemic stroke. Int J Cardiol 2016;215:11-13
- Friberg L, Rosenqvist M, Lip GYH. Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study. Circulation 2012;125:2298-307
- Singer DE, Chang Y, Fang MC, et al. The net clinical benefit of warfarin anticoagulation in atrial fibrillation. Ann Intern Med 2009;151:297-305
- Banerjee A, Lane DA, Torp-Pedersen C, et al. Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a "real world" atrial fibrillation population: a modelling analysis based on a nationwide cohort study. Thromb Haemost 2012;107:584-9
- Cranston L, Dixon L. Emerging Trends in Adherence and Quality Measurement: What the Future Holds. http://www.pharmacytimes.com/publications/Directions-in-Pharmacy/2014/August2014/Emerging-Trends-in-Adherence-and-Quality-Measurement-What-the-Future-Holds. Published 2014. Accessed December 04, 2017
- Schwartz L, Rhoads J. Adherence's role in Medicare Part D star ratings. America's PHARMACIST. http://www.ncpa.co/pdf/the-big-picture-adherence-roles-in-medicare-part-d-star-ratings.pdf. Published 2014. Accessed December 05, 2016